Evidence map›Paper›PMID 37886167›Full record

ArticleFrontiers in oncology2023

CritCom: assessment of quality of interdisciplinary communication around deterioration in pediatric oncologic patients.

Jocelyn Rivera, Sara Malone, Maria Puerto-Torres, Kim Prewitt, Lara Counts, Parima Wiphatphumiprates, Firas Sakaan, Zebin Al Zebin, Anita V Arias, Parthasarathi Bhattacharyya and 15 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Jocelyn RiveraPediatric Emergency Department, Hospital Infantil Teletón de Oncología (HITO), Querétaro, Mexico.
Sara MaloneWashington University in St. Louis, Brown School, St. Louis, MO, United States.
Maria Puerto-TorresDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Kim PrewittWashington University in St. Louis, Brown School, St. Louis, MO, United States.
Lara CountsWashington University in St. Louis, Brown School, St. Louis, MO, United States.
Parima WiphatphumipratesDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Firas SakaanDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Zebin Al ZebinPediatric Hematology and Oncology, King Hussein Cancer Center, Amman, Jordan.
Anita V AriasDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Parthasarathi BhattacharyyaDepartment of Pediatric Oncology Critical Care, Tata Medical Center, Kolkata, India.
Sanjeeva GunasekeraDepartment of Pediatric Oncology National Cancer Institute, Maharagama, Sri Lanka.
Sherry JohnsonDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Joyce KambuguPediatric Oncology, Uganda Cancer Institute, Kampala, Uganda.
Erica C KayeDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Belinda MandrellDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Jennifer MackDepartment of Hematology and Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, United States.
Jennifer McArthurDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Alejandra MendezPediatric Intensive Care Unit, Unidad Nacional de Oncología pediátrica (UNOP), Guatemala City, Guatemala.
Lisa MorrisseyDepartment of Hematology and Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, United States.
Rana Sharara-ChamiPediatric Critical Care Medicine, American University of Beirut, Beirut, Lebanon.
Jennifer SnamanDepartment of Hematology and Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, United States.
Elizabeth SnidermanNorthern Alberta Children's Cancer Program, Stollery Children's Hospital, Edmonton, AB, Canada.
Douglas A LukeWashington University in St. Louis, Brown School, St. Louis, MO, United States.
Dylan E GraetzDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Asya AgulnikDivision of Critical Care Medicine, Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High-quality clinical care requires excellent interdisciplinary communication, especially during emergencies, and no tools exist to evaluate communication in critical care. We describe the development of a pragmatic tool focusing on interdisciplinary communication during patient deterioration (CritCom). Methods: The preliminary CritCom tool was developed after a literature review and consultation with a multidisciplinary panel of global experts in communication, pediatric oncology, and critical care to review the domains and establish content validity iteratively. Face and linguistic validity were established through cognitive interviews, translation, and linguistic synthesis. We conducted a pilot study among an international group of clinicians to establish reliability and usability. Results: After reviewing 105 potential survey items, we identified 52 items across seven domains. These were refined through cognitive interviews with 36 clinicians from 15 countries. CritCom was piloted with 433 clinicians (58% nurses, 36% physicians, and 6% other) from 42 hospitals in 22 countries. Psychometric testing guided the refinement of the items for the final tool. CritCom comprised six domains with five items each (30 total). The final tool has excellent reliability (Cronbach's alpha 0.81-0.86), usability (93% agree or strongly agree that the tool is easy to use), and similar performance between English and Spanish tools. Confirmatory factor analysis was used to establish the final 6-domain structure. Conclusions: CritCom is a reliable and pragmatic bilingual tool to assess the quality of interdisciplinary communication around patient deterioration for children in diverse resource levels globally. Critcom results can be used to design and evaluate interventions to improve team communication.

Indexed as

assessmentcommunicationcritical careinterdisciplinaryquality care

Identifiers

PMID37886167
PMCPMC10598383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.